BOSTON - Dan Barouch, MD, PhD, has been named Director of the Center for Virology and Vaccine Research (CVVR) in the Department of Medicine at Beth Israel Deaconess Medical Center (BIDMC).
This newly created Center represents the merger of the former Division of Viral Pathogenesis and Division of Vaccine Research. Barouch, a Professor of Medicine at Harvard Medical School, has led the Division of Vaccine Research since 2009. He has also recently served as interim chief of the Division of Viral Pathogenesis, assuming the role previously held by HIV vaccine pioneer Norman Letvin, MD, who passed away in May.
"Dr. Barouch will ensure that the vital work of all components of the combined divisions remain highly successful," said Mark Zeidel, MD, BIDMC Chairman of the Department of Medicine. "With the loss of Norm Letvin, which has been difficult for all in the HIV community and for all of us who knew him, Dr. Barouch has served in the interim role as chief of both his division and Dr. Letvin's division. In creating this combined Center, Dr. Barouch will help enhance the synergies of these two critically important programs, with the goal of continuing BIDMC's pioneering work in developing preventive strategies and treatments for HIV."
Barouch is a
summa cum laude MD graduate of Harvard Medical School and also holds a PhD degree in immunology from Oxford University, where he was the recipient of a British Marshall Scholarship. He completed his medical residency training and was a clinical fellow in Infectious Diseases at Massachusetts General Hospital and Brigham and Women's Hospital. He joined the Letvin laboratory as a postdoctoral research fellow in 1995 and has been a member of the BIDMC faculty ever since.
A world leader in the field of HIV research, Barouch's laboratory focuses on studying the immunology and virology of HIV-1 infection and developing novel vaccine strategies. He leads a large National Institutes of Health-funded Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Program that has developed a series of novel and promising HIV-1 vaccine candidates that are currently in clinical trials in both the United States and sub-Saharan Africa. His team is also a key part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD), the National Institutes of Health Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID) and the Ragon Institute of MGH, MIT, and Harvard.
Barouch is the recipient of numerous awards, including the Maxwell Finland Young Investigator Award from the Massachusetts Infectious Diseases Society and the 2012 Oswald Avery Award from the Infectious Diseases Society of America (IDSA). He has been elected to the American Society for Clinical Investigation and will serve as Chair of the AIDS Vaccine 2012 Conference, a premier international meeting sponsored by the Global HIV Vaccine Enterprise that will be held in Boston in September to advance HIV vaccine research worldwide.